Medicine
Halog 1 mg/mL topical solution
Halog 1 mg/mL topical solution is a prescription medicine containing Halcinonide for topical use, marketed by ER Squibb & Sons, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, avoid freezing and temperatures above 104° F.
Key facts
- Active ingredient (INN)
- Halcinonide
- Brand
- Halog
- Strength
- 1 mg/mL
- Dosage form
- Topical solution
- Route
- Topical
- Packs
- 20 mL, 60 mL, 1 bottle
- Marketing authorisation holder
- ER Squibb & Sons
- Manufacturers
- ER Squibb & SonsGenus Lifesciences
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, avoid freezing and temperatures above 104° F.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D07AD02 Halcinonide
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 2009
- Identifiers
- RxCUI 206550, 310669DailyMed set ID f6c7e87b-6629-4d68-ae46-add64ca9daab, 42dc0904-1800-5f3b-e063-6294a90a2ad2NDC 0003-0249, 64950-127Application NDA017823
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 20 mL in 1 bottle, plastic | 0003-0249-15 | ER Squibb & Sons | 1 January 2009 |
| 60 mL in 1 bottle, plastic | 0003-0249-20 | ER Squibb & Sons | 1 January 2009 |
| 1 bottle, plastic in 1 carton / 120 mL in 1 bottle, plastic | 64950-127-12 | Genus Lifesciences | 17 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 November 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Halcinonide 1 mg/mL topical solution.
Other strengths and forms of Halcinonide
Clinical summary
Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as cream and topical solution. MedsAcross supplies Halcinonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HalcinonideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Halog prescribing information (Genus Lifesciences) · U.S. National Library of Medicine, DailyMed
Need Halog 1 mg/mL topical solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.